OnCore Biopharma
About:
OnCore Biopharma, Inc. is a privately held biotechnology company.
Website: http://www.oncorebiopharma.com/
Description:
OnCore Biopharma, Inc. is a privately held biotechnology company focused on the research, development, and commercialization of therapies for the treatment of chronic hepatitis B virus (HBV) infection. OnCore has assembled a portfolio of novel product candidates with unique mechanisms of action for the treatment of hepatitis B and is focused on delivering a cure.
Total Funding Amount:
$1M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Doylestown, Pennsylvania, United States
Founded Date:
2012-01-01
Contact Email:
info(AT)oncorebiopharma.com
Founders:
Michael J. McElhaugh, Michael Sofia, Patrick Higgins
Number of Employees:
11-50
Last Funding Date:
2014-10-03
IPO Status:
Private
Industries:
© 2025 bioDAO.ai